HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sandra Goble Selected Research

niraparib

1/2019Comment on: "Cost-Effectiveness of Niraparib Versus Routine Surveillance, Olaparib and Rucaparib for the Maintenance Treatment of Patients with Ovarian Cancer in the United States".

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sandra Goble Research Topics

Disease

17Ovarian Neoplasms (Ovarian Cancer)
01/2024 - 01/2017
16Carcinoma (Carcinomatosis)
03/2023 - 01/2017
12Neoplasms (Cancer)
01/2024 - 03/2017
5Disease Progression
01/2024 - 01/2017
4Asthenia
01/2021 - 08/2017
4Fatigue
01/2021 - 08/2017
3Anemia
12/2022 - 08/2017
3Vomiting
11/2019 - 08/2017
3Nausea
11/2019 - 08/2017
2Neutropenia
12/2022 - 03/2017
2Fallopian Tube Neoplasms
12/2021 - 12/2021
1Heart Diseases (Heart Disease)
01/2022
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2022
1Cicatrix (Scar)
01/2021
1Pancreatic Neoplasms (Pancreatic Cancer)
01/2018
1Neoplasm Metastasis (Metastasis)
10/2017
1Thrombocytopenia (Thrombopenia)
03/2017
1Prostatic Neoplasms (Prostate Cancer)
06/2015
1Injection Site Reaction
06/2015
1Nocturia
10/2014
1Nocturnal Enuresis (Bedwetting)
09/2013
1Wounds and Injuries (Trauma)
08/2010
1Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
08/2010
1Infections
08/2010
1Pneumonia (Pneumonitis)
08/2010
1Sepsis (Septicemia)
08/2010
1Renal Insufficiency (Renal Failure)
08/2010

Drug/Important Bio-Agent (IBA)

26rucaparibIBA
03/2023 - 01/2017
17PlatinumIBA
01/2024 - 01/2017
15Poly(ADP-ribose) Polymerase InhibitorsIBA
01/2024 - 01/2017
4Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
01/2022 - 01/2017
3Poly Adenosine Diphosphate RiboseIBA
01/2022 - 01/2021
3Hemoglobins (Hemoglobin)IBA
01/2021 - 11/2017
2Aspartate Aminotransferases (Aspartate Transaminase)IBA
01/2021 - 08/2017
2Alanine Transaminase (SGPT)IBA
01/2021 - 08/2017
2Deamino Arginine Vasopressin (Desmopressin)FDA LinkGeneric
10/2014 - 09/2013
1Indicators and Reagents (Reagents)IBA
03/2023
1Death Domain ReceptorsIBA
12/2021
1Monoclonal AntibodiesIBA
12/2021
1NivolumabIBA
12/2021
1CreatinineIBA
01/2021
1Biomarkers (Surrogate Marker)IBA
01/2021
1chemotactic factor inactivatorIBA
01/2020
1niraparibIBA
01/2019
1olaparibIBA
01/2019
1DNA (Deoxyribonucleic Acid)IBA
01/2018
1AntigensIBA
10/2017
1Carboplatin (JM8)FDA LinkGeneric
03/2017
1acetyl- 2- naphthylalanyl- 3- chlorophenylalanyl- 1- oxohexadecyl- seryl- 4- aminophenylalanyl(hydroorotyl)- 4- aminophenylalanyl(carbamoyl)- leucyl- ILys- prolyl- alaninamideFDA Link
06/2015
1Gonadotropin-Releasing Hormone (GnRH)FDA Link
06/2015
1TabletsIBA
09/2013

Therapy/Procedure

13Drug Therapy (Chemotherapy)
01/2024 - 10/2017
13Therapeutics
01/2024 - 03/2017
1Cytoreduction Surgical Procedures
12/2021
1Aftercare (After-Treatment)
06/2015
1Length of Stay
08/2010